These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 17353290)
1. Murine aerosol challenge model of anthrax. Loving CL; Kennett M; Lee GM; Grippe VK; Merkel TJ Infect Immun; 2007 Jun; 75(6):2689-98. PubMed ID: 17353290 [TBL] [Abstract][Full Text] [Related]
2. Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection. Cote CK; Van Rooijen N; Welkos SL Infect Immun; 2006 Jan; 74(1):469-80. PubMed ID: 16369003 [TBL] [Abstract][Full Text] [Related]
3. Cytokine response to infection with Bacillus anthracis spores. Pickering AK; Osorio M; Lee GM; Grippe VK; Bray M; Merkel TJ Infect Immun; 2004 Nov; 72(11):6382-9. PubMed ID: 15501768 [TBL] [Abstract][Full Text] [Related]
4. An integrated experimental-computational approach for predicting virulence in New Zealand white rabbits and humans following inhalation exposure to Bacillus anthracis spores. Hess BM; Thomas DG; Weber TJ; Hutchison JR; Straub TM; Bruckner-Lea CJ; Powell JD; Kabilan S; Corley RA PLoS One; 2019; 14(7):e0219160. PubMed ID: 31260462 [TBL] [Abstract][Full Text] [Related]
5. Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model. Heine HS; Bassett J; Miller L; Hartings JM; Ivins BE; Pitt ML; Fritz D; Norris SL; Byrne WR Antimicrob Agents Chemother; 2007 Apr; 51(4):1373-9. PubMed ID: 17296745 [TBL] [Abstract][Full Text] [Related]
6. Fully virulent Bacillus anthracis does not require the immunodominant protein BclA for pathogenesis. Bozue J; Cote CK; Moody KL; Welkos SL Infect Immun; 2007 Jan; 75(1):508-11. PubMed ID: 17074844 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of recombinant anthrax vaccine against Bacillus anthracis aerosol spore challenge: preclinical evaluation in rabbits and Rhesus monkeys. Chawla A; Midha S; Bhatnagar R Biotechnol J; 2009 Mar; 4(3):391-9. PubMed ID: 19296443 [TBL] [Abstract][Full Text] [Related]
8. Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection. Crawford MA; Burdick MD; Glomski IJ; Boyer AE; Barr JR; Mehrad B; Strieter RM; Hughes MA PLoS Pathog; 2010 Nov; 6(11):e1001199. PubMed ID: 21124994 [TBL] [Abstract][Full Text] [Related]
9. Transport of Bacillus anthracis from the lungs to the draining lymph nodes is a rapid process facilitated by CD11c+ cells. Shetron-Rama LM; Herring-Palmer AC; Huffnagle GB; Hanna P Microb Pathog; 2010; 49(1-2):38-46. PubMed ID: 20188814 [TBL] [Abstract][Full Text] [Related]
12. Bacillus anthracis: interactions with the host and establishment of inhalational anthrax. Passalacqua KD; Bergman NH Future Microbiol; 2006 Dec; 1(4):397-415. PubMed ID: 17661631 [TBL] [Abstract][Full Text] [Related]
13. A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax. Oscherwitz J; Yu F; Cease KB J Immunol; 2010 Sep; 185(6):3661-8. PubMed ID: 20696862 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis. Welkos SL; Friedlander AM Microb Pathog; 1988 Jan; 4(1):53-69. PubMed ID: 3143893 [TBL] [Abstract][Full Text] [Related]
15. Progress and novel strategies in vaccine development and treatment of anthrax. Chitlaru T; Altboum Z; Reuveny S; Shafferman A Immunol Rev; 2011 Jan; 239(1):221-36. PubMed ID: 21198675 [TBL] [Abstract][Full Text] [Related]